RESPIEVENTS, VERSION 4.2— 510(k) K001369

Name: FDA 510(k) clearance K001369
Creator: U.S. Food and Drug Administration
Published: 2000-07-26

Substantially Equivalent

Non-Invasive Monitoring Systems, Inc.

FDA 510(k) clearance K001369 for RESPIEVENTS, VERSION 4.2, Substantially Equivalent on 2000-07-26. Applicant: Non-Invasive Monitoring Systems, Inc.. Device class: 2.

Clearance details

Applicant: Non-Invasive Monitoring Systems, Inc.
Product code: Code DQK
Device class: Class 2
Regulation: 21 CFR 870.1425
Advisory panel: Cardiovascular
Date received: 2000-05-01
Decision date: 2000-07-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami Beach, FL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DQK

view all

K253692 — AVVIGO+ Multi-Modality Guidance System2026-08-21
K262005 — Affera Integrated Mapping System2026-08-21
K253576 — CorVista System® with PCWP Add-On2026-07-26
K262006 — EnSite X EP System2026-07-15
K252978 — ScioCardio ECG Analysis Platform2026-07-09

More clearances from Non-Invasive Monitoring Systems, Inc.

view all

K012020 — RESPIEVENTS SOFTWARE IS EVENT DATA PROCESSING SOFWARE FOR A PC2001-08-21
K942771 — RESPIEVENTS1996-02-13
K942852 — RESPITRACE PT1996-02-13
K903011 — RESPITRACE PLUS, RESPIBANDS, AND RESPICENTRAL1991-03-29
K884959 — RESPITRAK1989-06-08

Adverse events under product code DQK

product code DQK

Death: 10
Injury: 225
Malfunction: 2,123
Other: 2
Total: 2,360

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.